DD231349A5 - Verfahren zur herstellung von oxysalicylsaeureamiden - Google Patents

Verfahren zur herstellung von oxysalicylsaeureamiden Download PDF

Info

Publication number
DD231349A5
DD231349A5 DD85272829A DD27282985A DD231349A5 DD 231349 A5 DD231349 A5 DD 231349A5 DD 85272829 A DD85272829 A DD 85272829A DD 27282985 A DD27282985 A DD 27282985A DD 231349 A5 DD231349 A5 DD 231349A5
Authority
DD
German Democratic Republic
Prior art keywords
group
compound
general formula
formula
groups
Prior art date
Application number
DD85272829A
Other languages
German (de)
English (en)
Inventor
Karl St Bengtsson
Thomas Hoegberg
Lars G Johansson
Tomas De Paulis
Hans E Peter
Marianne E Widman
Sven O Oegren
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD231349A5 publication Critical patent/DD231349A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD85272829A 1984-01-31 1985-01-29 Verfahren zur herstellung von oxysalicylsaeureamiden DD231349A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8400478A SE8400478D0 (sv) 1984-01-31 1984-01-31 Oxysalicylamido derivatives

Publications (1)

Publication Number Publication Date
DD231349A5 true DD231349A5 (de) 1985-12-24

Family

ID=20354529

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85272829A DD231349A5 (de) 1984-01-31 1985-01-29 Verfahren zur herstellung von oxysalicylsaeureamiden

Country Status (25)

Country Link
EP (1) EP0156776B1 (hu)
JP (1) JPH07103097B2 (hu)
AT (1) ATE41770T1 (hu)
AU (1) AU575113B2 (hu)
CA (1) CA1253869A (hu)
CY (1) CY1544A (hu)
DD (1) DD231349A5 (hu)
DE (1) DE3569111D1 (hu)
DK (1) DK38685A (hu)
ES (3) ES8609239A1 (hu)
FI (1) FI83771C (hu)
GB (1) GB2153354B (hu)
GR (1) GR850268B (hu)
HK (1) HK53090A (hu)
HU (1) HU198684B (hu)
IE (1) IE57888B1 (hu)
IS (1) IS1442B6 (hu)
MY (1) MY102377A (hu)
NO (1) NO171363C (hu)
NZ (1) NZ210939A (hu)
PH (2) PH22430A (hu)
PT (1) PT79900B (hu)
SE (1) SE8400478D0 (hu)
SG (1) SG35290G (hu)
ZA (1) ZA85158B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446147A (en) * 1992-04-03 1995-08-29 Trustees Of The University Of Pennsylvania Fluorinated and iodinated dopamine agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822110B2 (ja) * 1977-08-08 1983-05-06 塩野義製薬株式会社 ベンズアミド誘導体の合成法
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
SE411118B (sv) * 1978-03-23 1979-12-03 Astra Laekemedel Ab Ett forfarande for framstellning av 2,6-dialkoxibensamider med terapentiska egenskaper
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives

Also Published As

Publication number Publication date
IE850220L (en) 1985-07-31
SG35290G (en) 1990-07-13
ES550825A0 (es) 1987-08-16
EP0156776B1 (en) 1989-03-29
DE3569111D1 (en) 1989-05-03
NO850244L (no) 1985-08-01
NZ210939A (en) 1988-10-28
JPS60178859A (ja) 1985-09-12
CA1253869A (en) 1989-05-09
IS2974A7 (is) 1985-08-01
IS1442B6 (is) 1990-12-14
PT79900B (en) 1987-02-03
HUT37750A (en) 1986-02-28
GR850268B (hu) 1985-05-28
MY102377A (en) 1992-06-17
JPH07103097B2 (ja) 1995-11-08
ES8707712A1 (es) 1987-08-16
GB8502095D0 (en) 1985-02-27
DK38685D0 (da) 1985-01-29
SE8400478D0 (sv) 1984-01-31
GB2153354B (en) 1987-10-21
GB2153354A (en) 1985-08-21
FI83771B (fi) 1991-05-15
PH22430A (en) 1988-09-12
HK53090A (en) 1990-07-20
IE57888B1 (en) 1993-05-05
ES8801199A1 (es) 1987-12-16
FI83771C (fi) 1991-08-26
ES539955A0 (es) 1986-09-01
HU198684B (en) 1989-11-28
AU3808885A (en) 1985-08-08
NO171363C (no) 1993-03-03
DK38685A (da) 1985-08-01
ZA85158B (en) 1985-09-25
PH24046A (en) 1990-03-05
EP0156776A1 (en) 1985-10-02
ES8609239A1 (es) 1986-09-01
NO171363B (no) 1992-11-23
FI850398L (fi) 1985-08-01
CY1544A (en) 1991-03-22
PT79900A (en) 1985-02-01
FI850398A0 (fi) 1985-01-30
ATE41770T1 (de) 1989-04-15
AU575113B2 (en) 1988-07-21
ES550826A0 (es) 1987-12-16

Similar Documents

Publication Publication Date Title
EP0261539B1 (de) Substituierte Phenylsulfonamide
DE60102581T2 (de) Azabizyklische carbamate und ihre anwendung als antagonisten des alpha-7 nikotinischen acetylcholin rezeptors
DE2901032C2 (de) Substituierte Morpholin-Derivate und deren Verwendung
EP1694318B1 (de) (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum
DE69918590T2 (de) Substituierte Karbazole, Verfahren zu ihrer Herstellung und ihre Verwendung als sPLA2-Inhibitoren
DE3026201C2 (hu)
EP0778271A2 (de) Aminoalkyl-substituierte benzo-heterocyclische Verbindungen
DD201139A5 (de) Verfahren zur herstellung von (-)-n-methyl-3-(2-methylphenoxy)-3-phenylpropylamin und seinen pharmazeutisch unbedenklichen salzen
DE69724422T2 (de) Arylalkylpiperazin-verbindungen als antioxidantien
EP1487835B1 (de) Essig- und propionsäureamide
EP0177960B1 (de) Tetrahydronaphtalinderivate, Verfahren und Zwischenprodukte zu deren Herstellung sowie diese enthaltende Arzneimittel
DE60129829T2 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in der therapie
EP0149840B1 (de) Substituierte 5,11-Dihydro-6H-dibenz(b,e)azepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0726265B1 (de) Antineurodegenerativ wirksame 10-Aminoaliphatyl-dibenz- b,f oxepine
DE69912419T2 (de) Phenylsulfonamid-phenylethylamine nützlich als dopamin-rezeptoren
DE69734594T2 (de) Nmda (n-methyl-d-aspartate) antagonists
DE60009931T2 (de) Muscarin-antagonisten
EP1335720A1 (de) Sulfonamiden zur behandlung von erkrankungen des zentralen nervensystems
DD211552A5 (de) Verfahren zur herstellung von benzamidoverbindungen
EP0254955A2 (de) Substituierte Pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69919575T2 (de) Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten
EP0491263B1 (de) Phenylalkylaminoalkyl-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD231349A5 (de) Verfahren zur herstellung von oxysalicylsaeureamiden
EP0491243B1 (de) Alkylaminoalkylamin- und -äther- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0508370B1 (de) Kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel zur Behandlung von Erkrankungen des Zentralnervensystems und zur Förderung der cerebralen Durchblutung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee